Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome

Iranian Journal of Reproductive Medicine

Volumn 13, Issue 6, 2015, Pages 373-378

  Moti, Mahtab ^a   Amini, Leila ^b   Ardakani, Soheila Sadat Mirhoseini ^c   Kamalzadeh, Sara ^c   Masoomikarimi, Masoomeh ^d   Jafarisani, Moslem ^e  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; AOPP; CRP; Infertility; Polycystic ovary syndrome

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ADVANCED OXIDATION PROTEIN PRODUCT; C REACTIVE PROTEIN; CHOLESTEROL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRAN; IRANIAN PEOPLE; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD SAMPLING; DEFENSE MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84939149543     PISSN: 16806433     EISSN: 20082177     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R. Prevalence of the Polycystic Ovary Syndrome in unselected black and white Women of the Southeastern United States: A prospective study 1. J Clin Endocrinol Metab 1998; 83: 3078-3082.
2. Baillargeon J-P, Iuorno MJ, Nestler JE. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol 2003; 46: 325-340.
3. Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med 2014; 12: 481-486.
4. Akhbardeh M. Oxidative stress and antioxidant: Exposure and impact on female fertility. Iran J Reprod Med 2009; 7 (Suppl.): 1.
5. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 1997; 126: 32-35.
6. Slowińska-Srzednicka J, Zgliczyński S, Wierzbicki M, Srzednicki M, Stopińska-Gluszak U, Zgliczyński W, et al. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991; 14: 569-575.
7. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
8. Riemersma R, Wood D, Oliver M, Elton R, Macintyre C, Gey K. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1-5.
9. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006; 26: 1156-1162.
10. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
11. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.
12. Gu HF, Efendic S, Nordman S, Östenson CG, Brismar K, Brookes AJ, et al. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 2004; 53: 2137-2142.
13. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313.
14. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-724.
15. Sohal R. The free radical hypothesis of aging: an appraisal of the current status. Aging 1993; 5: 3-17.
16. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273: 59-63.
17. Garibaldi S, Valentini S, Aragno I, Pronzato MA, Traverso N, Odetti P. Plasma protein oxidation and antioxidant defense during aging. Int J Vitamin Nutr Res 2001; 71: 332-338.
18. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, Cand E and carotene. Lancet 1991; 337: 1-5.
19. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. VitaminE consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
20. Brousseau ME, Schaefer EJ. New targets for medical treatment of lipid disorders. Curr Atheroscler Rep 2002; 4: 343-349.